Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+158.6%
5Y CAGR+44.6%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+158.6%/yr
Annual compound
5Y CAGR
+44.6%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
6.3x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 151.59% |
| 2024 | 85.23% |
| 2023 | -15.76% |
| 2022 | 8.77% |
| 2021 | -250.88% |
| 2020 | 23.99% |
| 2019 | -60.88% |
| 2018 | -181.66% |
| 2017 | -79.19% |
| 2016 | -37.90% |